Richiedi info sul prodotto
Estimated delivery: 1-3 business days
Information on returns and shipments
Payment methods
Innoryos is a prepackaged intra-articular syringe based on highly purified sodium hyaluronate, indicated to improve connective tissue viscosity and relieve pain and limited joint mobility due to degenerative changes and osteoarthritis.
Pain and limited joint mobility in case of degenerative changes of the knee joint and other synovial joints, including osteoarthritis.
Sodium hyaluronate, acid hyaluronic acid.
Aqueous and physiological phosphate buffered saline solution, weak saline phosphate buffered saline solution, sterile, isotonic, and pyrogen-free.
The prepackaged syringe must be removed from its packaging. The protective cap must be removed from the Luer-Lock thread. Screw a suitable sterile injection needle onto the syringe. The use of a disposable needle is recommended. Before injection, it is necessary to remove the air from the syringe. The area of ​​skin intended for injection must be cleansed with an appropriate topical antiseptic product. In case of joint effusion, it is recommended to reduce the effusion by aspiration and to examine its bacterial etiology before proceeding with the injection of Innoryos. The hydrogel can be injected intra-articularly 1 to 5 times at intervals determined by the physician. The beneficial effects of a single treatment last at least 6 months. Treatment cycles can be repeated if necessary. Depending on the filling volume, several joints of a patient can be treated simultaneously. Any unused product should be discarded.
The product cannot be used in patients undergoing anticoagulant therapy such as Marcumar (phenprocoumon) or Coumadin (warfarin).
Since septic arthritis can be a serious side effect of treatment, please observe all precautions typical of surgical procedures. Hydrogel injections must be administered precisely into the knee cavity; Avoid injections into blood vessels and adjacent tissue. Do not use if the prepackaged syringe or sterile packaging is damaged. The opened product cannot be resterilized, resealed, or reused. Use is reserved for a single patient in a single application session.
Medical personnel must inform the patient:
The product must be stored out of the reach of children. Use intended only by physicians. Single use only. Do not resterilize. Do not use syringes, needles, and hydrogel from opened or damaged packages, and do not attempt to reseal the packages. The contents of the syringe are non-toxic and non-flammable. If a product is used from damaged packaging or if it is reused for other patients or for the same patient at a later time, the intended properties and sterility are not guaranteed. Failure to comply with these instructions could result in the possible transmission of contaminated material and pathogens from the environment, the clinical environment, or (other) patients, which could lead to health complications. Reclosing or resterilizing does not constitute a permitted or guaranteed reconstitution of the usable state. Unused syringes and their contents are non-infectious and can be disposed of both before and after their expiration date, in compliance with national and local regulations. Used syringes and needles must be considered epidemiologically hazardous waste and disposed of in accordance with national and local regulations for safe use and disposal.
The product cannot be used in patients with:
Local phenomena such as pain, redness, swelling, and redness may occur in the treated joint. sensation of heat and swelling. These phenomena can be avoided by cooling the treated area with an ice pack for about 5-10 minutes after the injection. During the first few days of treatment, it may be helpful to take oral painkillers and anti-inflammatory drugs (NSAIDs). If intense redness or inflammation occurs, treatment should be discontinued. Treatment of adverse reactions should be performed exclusively under the supervision of a doctor. Immediately after the injection, it is necessary to avoid strenuous physical activity and follow the doctor's instructions.
Since there are no clinical data available regarding the use of hyaluronic acid in children, pregnant, or breastfeeding women, its use is not recommended for these groups.
The product must be stored in a dry place at a temperature between 2°C and 25°C, protected from light and shock, in its original packaging. It is therefore necessary to respect the warning symbols on the packaging.
Box with 2 ml syringe.
This product has been on sale since 31/10/2025
In the last 30 days, the product's lowest price was 142,87 €
Estimated delivery: 1-3 business days
Estimated delivery: 1-3 business days
Estimated delivery: 1-3 business days
Estimated delivery: 1-3 business days
